Evidence-Based Compounds for Chronic Inflammation
Chronic low-grade inflammation underlies cardiovascular disease, diabetes, neurodegeneration, and accelerated aging. NF-κB, COX-2, TNF-α, and IL-6 are the primary therapeutic targets. Natural compounds with the strongest clinical evidence for reducing inflammatory biomarkers are ranked below by evidence strength from the BiohacksAI corpus.
This page presents computational analysis of published research from PubMed/NCBI, BindingDB, and Reactome. Rankings are based on BiohacksAI discovery score, pathway overlap, and study count. This is not medical advice — consult a healthcare professional before starting any supplement.
Browse all compounds · Biological pathways · Molecular targets · All conditions
© Organiq Sweden AB · Patent pending EVE-PAT-2026-001